JT
SNDX icon

Jupiter Topco’s Syndax Pharmaceuticals SNDX Stock Holding History

Jupiter Topco’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$860K Buy
+39,335
New +$818K ﹤0.01% 1861

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco's SNDX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 39,335 shares worth $860K. The stake represents ﹤0.01% of the portfolio and ranks #1861 among its holdings.

218 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Jupiter Topco held 39,335 shares of Syndax Pharmaceuticals worth $860K as of Q2 2026.
  • Syndax Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1861 holding.
  • 218 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.